Professor Ansu Satpathy is a co-founder of Cartography Biosciences. Ansu is a physician-scientist who has pioneered the development and use of high-throughput genome sequencing technologies to study cancer immunology. Ansu is an Assistant Professor in the Department of Pathology at Stanford University. He is an investigator in the Gladstone-UCSF Institute of Genomic Immunology, the Parker Institute for Cancer Immunotherapy, and the Stanford Cancer Institute. In his spare time, he enjoys spending time with his children and cheering on the Warriors.
Recent Posts
- Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens
- Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer
- Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic
- Cartography Names Dirk Nagorsen, M.D., as Chief Medical Officer in Expansion of Its Clinical Team
- Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors
Recent Comments
No comments to show.